BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q1 2025 Earnings Call Transcript April 29, 2025
BridgeBio Pharma, Inc. beats earnings expectations. Reported EPS is $-0.88, expectations were $-1.
Operator: Good afternoon. I will be your conference operator today. All lines have been placed on mute to prevent any background noise. After the company’s remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. Before we begin, I would like to remind everyone that today’s...
